Patient and parent preferences for haemophilia A treatments.
about
The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics.Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection.Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies.Emerging drugs for the treatment of hemophilia A and B.Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment.
P2860
Patient and parent preferences for haemophilia A treatments.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Patient and parent preferences for haemophilia A treatments.
@en
Patient and parent preferences for haemophilia A treatments.
@nl
type
label
Patient and parent preferences for haemophilia A treatments.
@en
Patient and parent preferences for haemophilia A treatments.
@nl
prefLabel
Patient and parent preferences for haemophilia A treatments.
@en
Patient and parent preferences for haemophilia A treatments.
@nl
P2093
P2860
P1433
P1476
Patient and parent preferences for haemophilia A treatments.
@en
P2093
A F Mohamed
J D Epstein
J M Li-McLeod
P2860
P304
P356
10.1111/J.1365-2516.2010.02411.X
P577
2010-11-11T00:00:00Z